Federal officials on Thursday approved a new type of pain drug designed to eliminate the risks of addiction and overdose ...

Reversing opioid overdoses in rats using a drug that does not enter the brain prevents the sudden and severe withdrawal symptoms associated with therapeutics that target the central nervous system.

An online-based mindfulness treatment program significantly reduced opioid craving among participants with opioid use disorder results from a randomized clinical trial published in JAMA Network Open ...

For people who study the opioid epidemic, 2025 marks a grim anniversary: It has been 30 years since the Food and Drug ...

Around two-thirds of people relapse within 30 days after being discharged from residential treatment. An app could help them ...

The new drug is intended for treatment ... on opioids, contributing to dependency and misuse," he told Fox News Digital. "Suzetrigine’s non-opioid mechanism eliminates risks of misuse, addiction ...

WASHINGTON (AP) — Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and overdose associated with opioid medications like Vicodin and ...

The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...

A recent study explodes the myth that the risk of addiction ... or severe opioid use disorder severe enough to merit methadone, buprenorphine or other medication-assisted treatment.

The New York State health department is underscoring the importance of addiction medication in ending the opioid crisis.

Several agencies knowledgeable about opioids and opioid addiction are receiving funds from Butler County’s share of opioid settlement money — splitting $736,490 between six programs. The organization ...

It's the first new pharmaceutical approach to treating pain in over 20 years, designed to eliminate risks of addiction and ...